A novel pathogenic germline chromosome 3 inversion in von Hippel-Lindau disease
Cathy D. Vocke(National Cancer Institute), W. Marston Linehan(National Cancer Institute), Stephen M. Hewitt(National Institutes of Health), Krista Reynolds(National Institutes of Health), Svetlana Pack(National Cancer Institute), Mark W. Ball(Johns Hopkins University), Maria J. Merino(National Institutes of Health), Mark Raffeld(National Cancer Institute), Alexandra Lebensohn(National Institutes of Health), Rabindra Gautam(National Institutes of Health), Emily Y. Chew(National Institutes of Health), Prashant Chittaboina(National Institutes of Health), Laura S. Schmidt(Leidos (United States)), C. Ricketts(National Cancer Institute), Alex P. Kenigsberg(National Institutes of Health), Kristin Choo(National Institutes of Health), Naris Nilubol(National Institutes of Health), Lidenys O'Brien(National Institutes of Health), Sandeep Gurram(National Institutes of Health)
Cited by 1
Related Papers
Next-generation genotype imputation service and methods
|Nature Genetics|2016|4.5k
Targeting Tumor-Infiltrating Macrophages Decreases Tumor-Initiating Cells, Relieves Immunosuppression, and Improves Chemotherapeutic Responses
|Cancer Research|2012|941
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma
|Cell Reports|2018|818
Seven new loci associated with age-related macular degeneration
|Nature Genetics|2013|802